| Literature DB >> 35647681 |
Hideo Okumura1, Naoki Sakai1, Hironori Murakami1, Nobuhiro Mizuno1, Yuki Nakamura1, Go Ueno2, Takuya Masunaga1, Takashi Kawamura1, Seiki Baba1, Kazuya Hasegawa1, Masaki Yamamoto2, Takashi Kumasaka1.
Abstract
In situ diffraction data collection using crystallization plates has been utilized for macromolecules to evaluate crystal quality without requiring additional sample treatment such as cryocooling. Although it is difficult to collect complete data sets using this technique due to the mechanical limitation of crystal rotation, recent advances in methods for data collection from multiple crystals have overcome this issue. At SPring-8, an in situ diffraction measurement system was constructed consisting of a goniometer for a plate, an articulated robot and plate storage. Using this system, complete data sets were obtained utilizing the small-wedge measurement method. Combining this system with an acoustic liquid handler to prepare protein-ligand complex crystals by applying fragment compounds to trypsin crystals for in situ soaking, binding was confirmed for seven out of eight compounds. These results show that the system functioned properly to collect complete data for structural analysis and to expand the capability for ligand screening in combination with a liquid dispenser. open access.Entities:
Keywords: crystallization plates; in situ X-ray diffraction; ligand screening; protein crystallography; room-temperature data collection
Mesh:
Substances:
Year: 2022 PMID: 35647681 PMCID: PMC9158660 DOI: 10.1107/S2053230X22005283
Source DB: PubMed Journal: Acta Crystallogr F Struct Biol Commun ISSN: 2053-230X Impact factor: 1.072
Figure 1In situ diffraction measurement system using a crystallization plate installed in the experimental hutch at BL26B1 at SPring-8. (a) The articulated robot for crystallization plate transfer and plate storage. The circle indicates the position of the goniometer for a plate. (b) The goniometer for a plate. Red arrows indicate the rotation axis and the directions of movement of each axis. (c) Crystallization plates are transferred from a plate hotel to a plate stand by the robotic hand inside the plate storage. (d) Supply window on the side of the plate storage.
Specifications of the goniometer for a plate
| Main rotation axis | Horizontal pulse motor |
|---|---|
| Effective oscillation range (°) | −5 to 9 |
| Rotation speed (deg s−1) | 2.0 |
| Rotation resolution (°) | 0.005 |
| Horizontal travel range (mm) | 150 |
| Vertical travel range (mm) | 80 |
| Travel range along the beam (mm) | 20 |
| Translation speed (mm s−1) | 10 |
Figure 2Two switchable measurement modes. (a) Diffraction measurement mode using the goniometer for a sample pin for cryogenic measurement. (b) Crystallization plate diffraction measurement mode. Red arrows indicate the direction of movement of the goniometer for a sample pin, the goniometer for a plate and the cryo nozzle.
Figure 3The graphical user interface dedicated to the plate diffraction measurements. It consists of a main operation window, a crystal well selection window and a crystal centering window.
Data-collection statistics of samples for equipment evaluation
Values in parentheses are for the outer shell.
| Name of protein | Lysozyme | Thermolysin | Trypsin |
|---|---|---|---|
| Beamline | BL26B1, SPring-8 | BL26B1, SPring-8 | BL26B1, SPring-8 |
| Wavelength (Å) | 1.0000 | 1.0000 | 1.0000 |
| Space group |
|
|
|
|
| 78.57, 78.57, 37.60 | 92.97, 92.97, 130.30 | 54.90, 58.36, 67.77 |
| Resolution range (Å) | 50.0–1.42 (1.51–1.42) | 50.0–1.54 (1.63–1.54) | 50.0–1.33 (1.38–1.33) |
| No. of crystals | 20 | 20 | 20 |
| Total no. of reflections | 290097 (49786) | 942733 (149647) | 286972 (46735) |
| No. of unique reflections | 22844 (3781) | 49679 (7662) | 50333 (7989) |
| Completeness (%) | 100.0 (100.0) | 99.7 (99.9) | 99.6 (99.9) |
| Multiplicity | 12.70 (13.17) | 18.98 (19.53) | 5.70 (5.85) |
| 〈 | 13.82 (1.01) | 12.85 (1.07) | 10.95 (1.83) |
|
| 10.1 (231.5) | 17.6 (313.4) | 9.0 (92.6) |
| CC1/2 | 99.9 (51.0) | 99.8 (49.7) | 99.8 (71.6) |
R r.i.m. = R meas = .
Figure 4Results of small-wedge data collections. (a) Dendrogram for small-wedge measurement data of trypsin crystals. (b, c) Relationship between resolution (b) and completeness (c) and the number of measured crystals.
Statistics of each cluster in the merged small-wedge data set of trypsin crystals
| Cluster | No. of crystals | Cluster height | Completeness (overall) (%) | Multiplicity (overall) |
|---|---|---|---|---|
| 19 | 20 | 11.4 | 99.8 | 7.4 |
| 17 | 10 | 6.4 | 93.9 | 3.9 |
| 18 | 10 | 6.8 | 96.8 | 3.8 |
| 14 | 7 | 2.2 | 89.3 | 2.9 |
| 12 | 6 | 1.7 | 82.5 | 2.7 |
| 16 | 4 | 2.9 | 68.2 | 2.2 |
| 10 | 4 | 0.9 | 75.9 | 2.0 |
| 13 | 4 | 1.8 | 76.5 | 1.9 |
| 11 | 3 | 1.1 | 60.5 | 1.8 |
| 15 | 3 | 2.3 | 61.2 | 1.8 |
| 8 | 3 | 0.7 | 65.1 | 1.7 |
| 9 | 3 | 0.9 | 67.7 | 1.6 |
| 5 | 3 | 0.7 | 69.6 | 1.6 |
| 7 | 2 | 0.7 | 47.9 | 1.5 |
| 2 | 2 | 0.4 | 48.4 | 1.5 |
| 4 | 2 | 0.6 | 51.5 | 1.4 |
| 3 | 2 | 0.5 | 51.2 | 1.4 |
| 1 | 2 | 0.2 | 52.3 | 1.4 |
| 6 | 2 | 0.7 | 52.5 | 1.4 |
Data-collection and refinement statistics for trypsin crystals in complex with ligands
Values in parentheses are for the outer shell.
| Ligand | Benzamidine | 4-Methoxybenzamidine | 4-Bromobenzamidine | Serotonin | 5-Methoxytryptamine | 5-Chlorotryptamine | Tryptamine |
|---|---|---|---|---|---|---|---|
| Data-collection and merging statistics | |||||||
| Date | 29 June 2021 | 22 June 2021 | 29 June 2021 | 29 June 2021 | 22 June 2021 | 22 June 2021 | 22 June 2021 |
| Beamline | BL26B1, SPring-8 | BL26B1, SPring-8 | BL26B1, SPring-8 | BL26B1, SPring-8 | BL26B1, SPring-8 | BL26B1, SPring-8 | BL26B1, SPring-8 |
| Wavelength (Å) | 1.0000 | 1.0000 | 1.0000 | 1.0000 | 1.0000 | 1.0000 | 1.0000 |
| Space group |
|
|
|
|
|
|
|
|
| 54.58, 58.13, 67.35 | 54.58, 58.30, 67.30 | 54.57, 58.28, 67.35 | 54.66, 58.17, 67.34 | 54.60, 58.38, 67.20 | 54.58, 58.22, 67.26 | 54.61, 58.14, 67.36 |
| Resolution range (Å) | 50.0–1.77 (1.88–1.77) | 50.0–1.52 (1.61–1.52) | 50.0–1.48 (1.57–1.48) | 50.0–1.45 (1.54–1.45) | 50.0–1.38 (1.46–1.38) | 50.0–1.56 (1.65–1.56) | 50.0–1.45 (1.54–1.45) |
| No. of crystals | 16 | 9 | 13 | 13 | 15 | 16 | 10 |
| Total No. of reflections | 109342 (17523) | 107283 (17236) | 166794 (27140) | 184387 (30773) | 221492 (34007) | 162352 (25015) | 140789 (23301) |
| No. of unique reflections | 21236 (3432) | 30897 (4690) | 36057 (5741) | 38213 (6221) | 44589 (6834) | 30860 (4669) | 37261 (6055) |
| Completeness (%) | 98.3 (98.4) | 91.4 (88.9) | 98.7 (98.7) | 98.5 (99.0) | 99.3 (99.6) | 98.8 (98.8) | 96.1 (96.4) |
| Multiplicity | 5.15 (5.11) | 3.47 (3.68) | 4.63 (4.73) | 4.75 (4.95) | 4.97 (4.98) | 5.26 (5.36) | 3.78 (3.81) |
| 〈 | 10.03 (2.36) | 7.80 (2.48) | 7.52 (2.06) | 7.84 (1.80) | 11.12 (1.60) | 7.97 (1.79) | 9.22 (2.14) |
|
| 19.7 (149.4) | 17.7 (121.2) | 22.5 (126.8) | 15.5 (120.7) | 9.0 (129.4) | 25.1 (207.5) | 14.5 (133.1) |
| CC1/2 | 99.0 (49.9) | 98.7 (53.5) | 97.9 (51.6) | 99.0 (53.5) | 99.8 (52.8) | 98.5 (49.5) | 99.2 (50.1) |
| Overall | 16.7 | 11.2 | 16.7 | 14.0 | 15.4 | 15.0 | 13.7 |
| Model refinement | |||||||
| No. of reflections, working set | 20176 | 29328 | 34218 | 36240 | 42442 | 29267 | 35353 |
| No. of reflections, test set | 1025 | 1532 | 1801 | 1925 | 2224 | 1550 | 1879 |
|
| 13.46/19.90 | 13.35/17.75 | 13.84/18.06 | 13.07/17.22 | 13.02/16.52 | 13.99/18.99 | 13.47/17.35 |
| No. of non-H atoms | |||||||
| Protein | 1629 | 1629 | 1629 | 1629 | 1629 | 1629 | 1629 |
| Ion | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Ligand | 13 | 15 | 14 | 17 | 18 | 17 | 16 |
| Water | 87 | 103 | 130 | 129 | 118 | 116 | 118 |
| Total | 1730 | 1748 | 1774 | 1776 | 1766 | 1763 | 1764 |
| R.m.s. deviations | |||||||
| Bond lengths (Å) | 0.014 | 0.016 | 0.019 | 0.016 | 0.019 | 0.016 | 0.016 |
| Bond angles (°) | 1.772 | 1.732 | 1.949 | 1.746 | 1.867 | 1.798 | 1.817 |
| Average | 18.7 | 14.0 | 11.5 | 15.9 | 17.2 | 14.4 | 15.7 |
| Ramachandran plot | |||||||
| Favored region (%) | 99.1 | 98.6 | 98.6 | 98.6 | 98.2 | 98.2 | 98.2 |
| Additionally allowed (%) | 0.9 | 1.4 | 1.4 | 1.4 | 1.8 | 1.8 | 1.8 |
| Outliers (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PDB code |
|
|
|
|
|
|
|
R r.i.m. = R meas = .
Figure 5Crystal structures of the ligand-binding region of trypsin in complex with (a) benzamidine, (b) 4-methoxybenzamidine, (c) 4-bromobenzamidine, (d) serotonin, (e) 5-methoxytryptamine, (f) 5-chlorotryptamine and (g) tryptamine. The omit maps contoured at 3.0σ are shown as a mesh.